Runtime
16:00
The American Association of Cancer Research speaks with James P. Allison, director of the Ludwig Center for Cancer Immunotherapy at Memorial Sloan-Kettering Cancer Center. He discusses his work at the forefront of immunotherapeutics and the development of ipilimumab, the first immunotherapy to show improved survival in patients with advanced melanoma.
Speaker(s)
James Allison
See Videos Related to:
